B

Boditech Med Inc
KOSDAQ:206640

Watchlist Manager
Boditech Med Inc
KOSDAQ:206640
Watchlist
Price: 17 650 KRW -0.06% Market Closed
Updated: May 31, 2024

Profitability Summary

Boditech Med Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Boditech Med Inc

Revenue
134.2B KRW
Cost of Revenue
-53.3B KRW
Gross Profit
80.9B KRW
Operating Expenses
-52.4B KRW
Operating Income
28.5B KRW
Other Expenses
-2.5B KRW
Net Income
25.9B KRW

Margins Comparison
Boditech Med Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
Boditech Med Inc
KOSDAQ:206640
387.7B KRW
60%
21%
19%
US
Abbott Laboratories
NYSE:ABT
176.7B USD
55%
16%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.3B USD
66%
25%
27%
US
Stryker Corp
NYSE:SYK
129.6B USD
64%
21%
16%
US
Boston Scientific Corp
NYSE:BSX
109.7B USD
69%
17%
12%
IE
Medtronic PLC
NYSE:MDT
106.2B USD
66%
20%
11%
US
Becton Dickinson and Co
NYSE:BDX
66.6B USD
41%
11%
7%
DE
Siemens Healthineers AG
XETRA:SHL
59.7B EUR
38%
12%
8%
US
Edwards Lifesciences Corp
NYSE:EW
52B USD
77%
29%
23%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
350.9B CNY
65%
35%
34%
US
Dexcom Inc
NASDAQ:DXCM
46.4B USD
63%
17%
17%
Country KR
Market Cap 387.7B KRW
Gross Margin
60%
Operating Margin
21%
Net Margin
19%
Country US
Market Cap 176.7B USD
Gross Margin
55%
Operating Margin
16%
Net Margin
14%
Country US
Market Cap 141.3B USD
Gross Margin
66%
Operating Margin
25%
Net Margin
27%
Country US
Market Cap 129.6B USD
Gross Margin
64%
Operating Margin
21%
Net Margin
16%
Country US
Market Cap 109.7B USD
Gross Margin
69%
Operating Margin
17%
Net Margin
12%
Country IE
Market Cap 106.2B USD
Gross Margin
66%
Operating Margin
20%
Net Margin
11%
Country US
Market Cap 66.6B USD
Gross Margin
41%
Operating Margin
11%
Net Margin
7%
Country DE
Market Cap 59.7B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country US
Market Cap 52B USD
Gross Margin
77%
Operating Margin
29%
Net Margin
23%
Country CN
Market Cap 350.9B CNY
Gross Margin
65%
Operating Margin
35%
Net Margin
34%
Country US
Market Cap 46.4B USD
Gross Margin
63%
Operating Margin
17%
Net Margin
17%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Boditech Med Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
Boditech Med Inc
KOSDAQ:206640
387.7B KRW
15%
12%
15%
17%
US
Abbott Laboratories
NYSE:ABT
176.7B USD
15%
8%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.3B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
129.6B USD
19%
9%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
109.7B USD
9%
5%
8%
6%
IE
Medtronic PLC
NYSE:MDT
106.2B USD
7%
4%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
66.6B USD
5%
2%
5%
4%
DE
Siemens Healthineers AG
XETRA:SHL
59.7B EUR
10%
4%
8%
5%
US
Edwards Lifesciences Corp
NYSE:EW
52B USD
22%
15%
22%
22%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
350.9B CNY
36%
25%
34%
46%
US
Dexcom Inc
NASDAQ:DXCM
46.4B USD
29%
11%
15%
18%
Country KR
Market Cap 387.7B KRW
ROE
15%
ROA
12%
ROCE
15%
ROIC
17%
Country US
Market Cap 176.7B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
9%
Country US
Market Cap 141.3B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 129.6B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country US
Market Cap 109.7B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
6%
Country IE
Market Cap 106.2B USD
ROE
7%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 66.6B USD
ROE
5%
ROA
2%
ROCE
5%
ROIC
4%
Country DE
Market Cap 59.7B EUR
ROE
10%
ROA
4%
ROCE
8%
ROIC
5%
Country US
Market Cap 52B USD
ROE
22%
ROA
15%
ROCE
22%
ROIC
22%
Country CN
Market Cap 350.9B CNY
ROE
36%
ROA
25%
ROCE
34%
ROIC
46%
Country US
Market Cap 46.4B USD
ROE
29%
ROA
11%
ROCE
15%
ROIC
18%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More